Showing results (1-10 of 307) with videos related to
Sort By:
Pageof 31
Expert Opinion on Investigational Drugs|April 17, 2012
A potential role for nilotinib in KIT-mutated melanomaAn Tran, Hussein A TawbiCancer Journal (Sudbury, Mass.)|March 25, 2024
Local and Systemic Management Options for Melanoma Brain MetastasesAfsaneh Amouzegar, Hussein A TawbiNeuro-Oncology Advances|December 3, 2021
Emergent immunotherapy approaches for brain metastasesJianbo Wang, Hussein A TawbiAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 19, 2021
Nonsurgical Management of Melanoma Brain Metastasis: Current Therapeutics, Challenges, and Strategies for ProgressShalini Makawita, Hussein A TawbiTherapeutic Advances in Medical Oncology|July 24, 2023
The introduction of LAG-3 checkpoint blockade in melanoma: immunotherapy landscape beyond PD-1 and CTLA-4 inhibitionFiras Y Kreidieh, Hussein A TawbiClinical Advances in Hematology & Oncology : H&O|October 7, 2022
Current and emerging options for patients with melanoma brain metastasesFiras Y Kreidieh, Hussein A TawbiSeminars in Oncology|December 18, 2007
Management of metastatic melanomaHussein A Tawbi, John M KirkwoodCancer Discovery|May 5, 2021
Bispecific Antibodies to PD-1 and CTLA4: Doubling Down on T Cells to Decouple Efficacy from ToxicityElizabeth M Burton, Hussein A TawbiCancer Discovery|August 5, 2018
Engineered T Cells in Synovial Sarcoma: Persistence Pays Off!Emily Z Keung, Hussein A TawbiClinical Advances in Hematology & Oncology : H&O|May 28, 2010
Chemotherapy resistance abrogation in metastatic melanomaHussein A Tawbi, Shama C BuchPageof 31